BRIAN A. MARKISON - 04 Nov 2021 Form 4 Insider Report for Osmotica Pharmaceuticals plc (RVLP)

Role
Chief Executive Officer, Director
Signature
/s/ Christopher Klein, as attorney-in-fact
Issuer symbol
RVLP
Transactions as of
04 Nov 2021
Transactions value $
$0
Form type
4
Filing time
08 Nov 2021, 15:05:57 UTC
Previous filing
12 May 2021
Next filing
12 May 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RVLP Share Option (Right to Buy) Award $0 +615K $0.00 615K 04 Nov 2021 Ordinary Shares 615K $1.80 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 25% of the ordinary shares underlying the award on the first anniversary of the grant and as to the remaining 75% of the shares in thirty-six (36) equal monthly installments thereafter.